Troyen A. Brennan - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Chief Medical Officer
Signature
/s/ Troyen Brennan
Issuer symbol
CVS
Transactions as of
01 Apr 2022
Net transactions value
-$8,101,252
Form type
4
Filing time
05 Apr 2022, 19:36:21 UTC
Previous filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability $7,880,976 -77,960 -25% $101.09 234,855 01 Apr 2022 Direct F1
transaction CVS Common Stock Tax liability $220,275 -2,179 -0.93% $101.09 232,676 03 Apr 2022 Direct F2
holding CVS Common Stock (restricted) 4,805 01 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 53,772 01 Apr 2022 Common Stock 53,772 $104.82 Direct F3
holding CVS Stock Option 75,134 01 Apr 2022 Common Stock 75,134 $78.05 Direct F4
holding CVS Stock Option 21,894 01 Apr 2022 Common Stock 21,894 $62.21 Direct F5
holding CVS Stock Option 80,803 01 Apr 2022 Common Stock 80,803 $54.19 Direct F6
holding CVS Stock Option 84,478 01 Apr 2022 Common Stock 84,478 $58.34 Direct F7, F8
holding CVS Stock Option 99,344 01 Apr 2022 Common Stock 99,344 $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022.
F2 Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.